Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer

Clinical trial NCT01488552 · COMPLETED

Trial details

NCT number: NCT01488552
Sponsor: Pancreatic Cancer Research Team
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Stage IV Pancreatic Cancer

Start date: 2011-11-01
Primary completion: 2015-08-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.